JAVIER
SASTRE VALERA
Profesor asociado de Ciencias de la Salud
Mutua de Terrassa
Terrassa, EspañaPublicaciones en colaboración con investigadores/as de Mutua de Terrassa (5)
2022
-
Correction to: SEOM‑GEMCAD‑TTD clinical guidelines for localized rectal cancer (2021) (Clinical and Translational Oncology, (2022), 24, 4, (646-657), 10.1007/s12094-022-02816-9)
Clinical and Translational Oncology
-
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)
Clinical and Translational Oncology, Vol. 24, Núm. 4, pp. 646-657
2014
-
Prognostic factors for relapse in stage I seminoma: A new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)
Annals of Oncology, Vol. 25, Núm. 11, pp. 2173-2178
2011
-
Risk-adapted treatment in clinical stage I testicular seminoma: The third Spanish Germ Cell Cancer Group study
Journal of Clinical Oncology, Vol. 29, Núm. 35, pp. 4677-4681
2010
-
Practical prognostic index for patients with metastatic recurrent breast cancer: Retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register
Breast Cancer Research and Treatment, Vol. 122, Núm. 2, pp. 591-600